Estromustine Explained

Estromustine (developmental code name Leo 271 f), also known as estrone 17β-3-N-bis(2-chloroethyl)carbamate or estrone–cytostatic complex,^[1] is a major active metabolite of the cytostatic antineoplastic agent and estrogen estramustine phosphate, a medication used in the treatment of prostate cancer.^{[2] [3]}

See also

• List of hormonal cytostatic antineoplastic agents
• List of estrogen esters § Estradiol esters

Notes and References

1. Yamanaka H, Kitaura K, Imai K, Yuasa H, Nakai K, Matsumura Y, Uehara H, Shida K . In vivo studies of 3H-estramustine in castrated male rat . Acta Urologica Japonica . 1981 . 27 . 3 . 243–50 .
2. Book: Chabner BA, Longo DL . Cancer Chemotherapy and Biotherapy: Principles and Practice. 7 December 2011. Lippincott Williams & Wilkins. 978-1-4511-4820-6. 252–.
3. Book: Medical Subject Headings: Supplementary chemical records. 1993. The Library. 684.